Jan 21Liked by Anandamide

Sasha Latypova makes the case that it is technically impossible to scale up mRNA technology at present, and that AE variations in batches may be down to stratification in the vat, where all the broken fragments are floating in the nanolipid at the top, and the bottom consists of more inert material.

"Nobody Knows What is in the Vials" https://sashalatypova.substack.com/p/nobody-knows-what-is-in-the-vials

and that the DoD refers to the injections as "prototype demonstrations" https://sashalatypova.substack.com/p/the-role-of-the-us-dod-and-their

and that "Fake Western Blots Submitted by Pfizer to Several Regulatory Agencies" https://sashalatypova.substack.com/p/fake-western-blots-submitted-by-pfizer

"WHAT IS IN SO-CALLED COVID-19 "VACCINES"? Part 1: Evidence of a Global Crime Against Humanity" https://www.researchgate.net/publication/364819531_WHAT_IS_IN_SO-CALLED_COVID-19_VACCINES_Part_1_Evidence_of_a_Global_Crime_Against_Humanity


There are 52 covid vaccines in clinical trial in the US alone, 29 of which are mRNA/DNA https://covid19.trackvaccines.org/country/united-states-of-america/

And, in what I'm certain is merely a coincidence- "MRNA Cocktail Can Make Old Tissue Specific Cells Young" https://www.nextbigfuture.com/2022/03/mrna-cocktail-can-de-age-cells-and-retain-tissue-differentiation.html

Expand full comment
Jan 21Liked by Anandamide

A very interesting read!

Expand full comment

Just checking you have seen this study that shows vaxx mRNA (presumably in LNPs) in plasma for each of 16 subjects, out to 15 days: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313234/

I had a go at quantifying it - difficult as don't know the half life etc but I reckon at least a few % of the dose enters the bloodstream. This would be consistent with the luciferase biodistribution assay which showed about 5% active mRNA in liver (which must have got there thru the blood).

Expand full comment

Great post Kevin. You're writing's gotten clearer too

Expand full comment

How can this now pose a risk to the unvaccinated? All "mutations" should carry enough of the prior sequence for our Immune Systems to identify and deal with the variant.

I am not a fan of open ended statements :-)

I also agree with previous post, that ALLOT of what was sent out were all really "duds". At the onset, the race to secure market share was so desperate that allot of the product might have been LNP blanks. There is also good research on LNP failure following freezing. So a large majority of deaths could be the LNP "sludge" that was injected.

Expand full comment

Hi Kevin,

Have you seen any deep-sequencing reads that indicate there has been recombination between the vaccinal sequences and the various SarsCov2 variants?

It looks like the codon optimised “pseudo-mRNA” vaccines match the Wuhan spike at around ~85% at the nucleotide level, with plenty of 30+ exact identity regions throughout the spike ORF to provide plentiful template switching possibilities, even for a +ve str RNA virus.

Various chimeras appear to have been found between delta and omicron after (presumably) a coinfection. And it even appears various entirely new viral species have been formed similarly, including possibly SARS Season 1.

Repeatedly transfecting millions of people who are potentially infected, with the reportedly far milder omicron variants, with billions of copies of modified nucleic acids that could recombine with any replicating virus to restore some (all?) of the linked mutations that made the original strain more virulent, seems like a risky plan to me.

As for a “bivalent” booster, containing the template for a recent but outcompeted omicron spike mixed up with the original Wuhan spike, being transfected into cells that may be replicating even more homologous omicron RNA, seems even more likely to promote recombination, and thereby provide an intermediate that could help restore the full Wuhan spike, than the original monovalent vaccine.

Is it known if the spike ORF’s in the bivalent shots were codon re-“optimised” differently to the original vaccinal spike to reduce the possibility of recombination with one another? I’m guessing not, seeing as the people who designed these seem to be oblivious to or in denial of a huge variety of plausible issues, as you have so comprehensively demonstrated.

Also, given the heavy codon changes in the vaccinal sequences, would the sequencing primers used for the transcriptome sequencing bind to the vaccinal regions if so? Or put another way, do we know if the routine deep sequencing has even looked for vaccinal recombinants? This amazing deep-sequencing was well after my time…

I would find it very ironic if some of the S gene amplimer “drop out”, that appears to still (bizarrely) be used as a diagnostic for certain variants, is actually coming about through vaccinal spike recombinants. Why continue to use a negative result as a diagnostic??

And lastly - sorry for all the questions in one post - is it known if the LFTs would give a positive signal for a vaccinal spike recombinant if it arose? If neither PCR nor LFT detects such a recombinant, then there would be a selective advantage to any such detection-evading variant that arose, and such cases might never even be sampled for the deep-sequencing needed to detect their presence.

P.S. Thanks for all the awesome posts (and to get even nerdier, particularly the deep dive into the modern usage of Type IIs REs, so much easier to say than hapaxoterministic restriction enzymes as I was taught to call them in the UK. I had some “fun” with them back in the day - took me right back to the early days of my molbio career.)

Expand full comment

Fascinating and great detective work! Thank you.

Expand full comment

+1 for #FiatScience...I'll be spreading that one on #gab.

Expand full comment